成年人异常性炎症性肌肉病的治疗指南:比较性综述
Julie J Paik1, Victoria P Werth2,3, Hector Chinoy4,5
1Johns Hopkins University, School of Medicine, Division of Rheumatology, Baltimore, MD, USA.
Rheumatology (Oxford, England)
|February 25, 2025
概括
肌肉炎是一种罕见的自身免疫性疾病,由于症状多样化和研究有限,在管理方面存在挑战. 制定统一的全球指导方针对于有效治疗异形性炎症性肌肉病至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 神经学 神经学
背景情况:
- 肌肉炎,或异常性炎症性肌肉炎症,是一组由肌肉衰弱和炎症为特征的自身免疫性疾病.
- 由于疾病的稀有性,变异性和缺乏大规模随机对照试验,目前的管理具有挑战性.
- 现有的治疗建议在不同地区和疾病亚型之间存在显著差异,反映了有限的证据和多样化的做法.
研究的目的:
- 进行各种组织现有的肌肉炎治疗指南的比较审查.
- 识别诊断和管理方法中的相似之处和关键差异.
- 突出需要全球统一的,共识驱动的肌肉炎管理指南.
主要方法:
- 对已发表的肌肉炎治疗指南进行比较分析.
- 审查有关诊断,治疗和整体管理的建议.
- 综合发现,以确定共识和分歧的领域.
主要成果:
- 目前的肌肉炎治疗指南存在显著差异.
- 在经过审查的指南中,在诊断标准和治疗策略中发现了关键差异.
- 在治疗异形性炎症性肌肉病症方面缺乏全球标准化.
结论:
- 需要一个统一的,多学科的,共识驱动的方法来管理肌炎.
- 标准化的全球指导方针对于有效和一致的治疗固态炎症性肌肉病是必不可少的.
- 解决当前建议的变化将改善患者的护理和结果.
相关概念视频
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


